Drug Profile
Research programme: DNA synthesis inhibitors - Adriacell
Alternative Names: ADRIAC36; CROMOCLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Adriacell
- Class Proteins
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Italy
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Italy
- 20 Oct 2009 Early research in Inflammation in Italy (unspecified route)